Cargando…

Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India

Prevalence of immunoglobulin G (IgG) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in the industrial district of East Singhbhum (Jharkhand, India) from July, August, November, and December 2020 and January 2021 after the first wave and in July 2021 after the second wave of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nag, Deb Sanjay, Mishra, Minakshi, Chaudhry, Rajan, Rana, Farah, Rai, Sudhir, Mehta, Neelam, Gupta, Minakshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450014/
https://www.ncbi.nlm.nih.gov/pubmed/34557376
http://dx.doi.org/10.7759/cureus.18097
_version_ 1784569535860310016
author Nag, Deb Sanjay
Mishra, Minakshi
Chaudhry, Rajan
Rana, Farah
Rai, Sudhir
Mehta, Neelam
Gupta, Minakshi
author_facet Nag, Deb Sanjay
Mishra, Minakshi
Chaudhry, Rajan
Rana, Farah
Rai, Sudhir
Mehta, Neelam
Gupta, Minakshi
author_sort Nag, Deb Sanjay
collection PubMed
description Prevalence of immunoglobulin G (IgG) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in the industrial district of East Singhbhum (Jharkhand, India) from July, August, November, and December 2020 and January 2021 after the first wave and in July 2021 after the second wave of coronavirus disease 2021 (COVID-19) infections may be utilized to find the possibility of a third wave of COVID-19 infections. Based on the trend of the loss of protective IgG antibodies after the first wave and the seropositivity of 75% in the district in July 2021, simple forecasting and proportional estimates of the seropositivity in the next eight months and the estimated maximum number of the cases was done. We also considered the seropositivity without vaccination in July 2021 (63%). Additionally, the trend of the weekly RT-PCR and rapid antigen testing for SARS-CoV-2 may also preemptively predict an imminent wave. Based on the East Singhbhum population and the vaccination coverage with at least one dose till July 2021 (Covishield or Covaxin), it is estimated that a 4-5% monthly vaccination coverage rate of new individuals will not allow the seropositivity to fall below 50% and hold at bay a major wave. Vaccination coverage of 3% or less would allow a continuous drop in acquired immunity in the district and can potentially cause a rise in cases, making the community susceptible to a future surge of infections. A 3-5% vaccination rate of new individuals is unlikely to see a drop in the community seropositivity below 50% and the number of new cases of COVID-19 infections going above 478 to 712 per month at least till March 2022. The assumptions are based on presuming that there will be no new mutant of SARS-CoV-2 that escapes the immunity provided by previous infection or vaccination over the next eight months. However, currently, there is no evidence to speculate on any new variant of concern causing a major wave globally. The B.1.617.2 (delta) variant was first identified in October 2020 and there was a lag of six months to the second surge of COVID-19 infections in East Singhbhum, primarily caused by this variant. Additionally, 3% and above, with a rising weekly trend of reverse transcription-polymerase chain reaction (RT-PCR) positivity for SARS-CoV-2 can provide at least four to eight weeks advance warning before the peak of the wave if an imminent future wave is impending.
format Online
Article
Text
id pubmed-8450014
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-84500142021-09-22 Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India Nag, Deb Sanjay Mishra, Minakshi Chaudhry, Rajan Rana, Farah Rai, Sudhir Mehta, Neelam Gupta, Minakshi Cureus Allergy/Immunology Prevalence of immunoglobulin G (IgG) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in the industrial district of East Singhbhum (Jharkhand, India) from July, August, November, and December 2020 and January 2021 after the first wave and in July 2021 after the second wave of coronavirus disease 2021 (COVID-19) infections may be utilized to find the possibility of a third wave of COVID-19 infections. Based on the trend of the loss of protective IgG antibodies after the first wave and the seropositivity of 75% in the district in July 2021, simple forecasting and proportional estimates of the seropositivity in the next eight months and the estimated maximum number of the cases was done. We also considered the seropositivity without vaccination in July 2021 (63%). Additionally, the trend of the weekly RT-PCR and rapid antigen testing for SARS-CoV-2 may also preemptively predict an imminent wave. Based on the East Singhbhum population and the vaccination coverage with at least one dose till July 2021 (Covishield or Covaxin), it is estimated that a 4-5% monthly vaccination coverage rate of new individuals will not allow the seropositivity to fall below 50% and hold at bay a major wave. Vaccination coverage of 3% or less would allow a continuous drop in acquired immunity in the district and can potentially cause a rise in cases, making the community susceptible to a future surge of infections. A 3-5% vaccination rate of new individuals is unlikely to see a drop in the community seropositivity below 50% and the number of new cases of COVID-19 infections going above 478 to 712 per month at least till March 2022. The assumptions are based on presuming that there will be no new mutant of SARS-CoV-2 that escapes the immunity provided by previous infection or vaccination over the next eight months. However, currently, there is no evidence to speculate on any new variant of concern causing a major wave globally. The B.1.617.2 (delta) variant was first identified in October 2020 and there was a lag of six months to the second surge of COVID-19 infections in East Singhbhum, primarily caused by this variant. Additionally, 3% and above, with a rising weekly trend of reverse transcription-polymerase chain reaction (RT-PCR) positivity for SARS-CoV-2 can provide at least four to eight weeks advance warning before the peak of the wave if an imminent future wave is impending. Cureus 2021-09-19 /pmc/articles/PMC8450014/ /pubmed/34557376 http://dx.doi.org/10.7759/cureus.18097 Text en Copyright © 2021, Nag et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Allergy/Immunology
Nag, Deb Sanjay
Mishra, Minakshi
Chaudhry, Rajan
Rana, Farah
Rai, Sudhir
Mehta, Neelam
Gupta, Minakshi
Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India
title Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India
title_full Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India
title_fullStr Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India
title_full_unstemmed Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India
title_short Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India
title_sort results of serosurveillance and forecasting the third wave of covid-19 in an industrial district in india
topic Allergy/Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450014/
https://www.ncbi.nlm.nih.gov/pubmed/34557376
http://dx.doi.org/10.7759/cureus.18097
work_keys_str_mv AT nagdebsanjay resultsofserosurveillanceandforecastingthethirdwaveofcovid19inanindustrialdistrictinindia
AT mishraminakshi resultsofserosurveillanceandforecastingthethirdwaveofcovid19inanindustrialdistrictinindia
AT chaudhryrajan resultsofserosurveillanceandforecastingthethirdwaveofcovid19inanindustrialdistrictinindia
AT ranafarah resultsofserosurveillanceandforecastingthethirdwaveofcovid19inanindustrialdistrictinindia
AT raisudhir resultsofserosurveillanceandforecastingthethirdwaveofcovid19inanindustrialdistrictinindia
AT mehtaneelam resultsofserosurveillanceandforecastingthethirdwaveofcovid19inanindustrialdistrictinindia
AT guptaminakshi resultsofserosurveillanceandforecastingthethirdwaveofcovid19inanindustrialdistrictinindia